<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Inflammation, Inflammatory Disorders, and Wound Healing | Fundamentals of Pathology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="chapter-01-growth-adaptations.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">2</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">19</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 10%;"></div>
                            </div>
                            <span class="progress-label">Inflammation & Wound Healing</span>
                        </div>
                        
                        <a href="chapter-03-neoplasia.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Chapter 2</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">üî•</span>
                        <span class="badge-text">Pathology</span>
                    </div>
                    <h1 class="document-title">Inflammation, Inflammatory Disorders, and Wound Healing</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üìÑ</span>
                            <span>Chapter 2</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">
                    
                    <!-- Introduction -->
                    <section id="introduction" class="content-section">
                        <h2 class="section-title">Introduction</h2>
                        <div class="content-card">
                            <h3 id="intro-principles">I. Inflammation</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Allows inflammatory cells, plasma proteins (e.g., complement), and fluid to exit blood vessels and enter the interstitial space</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Divided into acute and chronic inflammation</div>
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Acute Inflammation -->
                    <section id="acute-inflammation" class="content-section">
                        <h2 class="section-title">Acute Inflammation</h2>

                        <div class="content-card">
                            <h3 id="acute-basic-principles">I. Basic Principles</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Characterized by the presence of edema and neutrophils in tissue (Fig. 2.1A)</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Arises in response to infection (to eliminate pathogen) or tissue necrosis (to clear necrotic debris)</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">Immediate response with limited specificity (innate immunity)</div>
                                </li>
                            </ul>
                            
                            <!-- Figure 2.1 -->
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-6be8af7a.jpeg" 
                                         alt="A, Acute inflammation with neutrophils. B, Chronic inflammation with lymphocytes and plasma cells." 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.1 Inflammation. A, Acute inflammation with neutrophils. B, Chronic inflammation with lymphocytes and plasma cells.</figcaption>
                            </figure>
                        </div>

                        <div class="content-card">
                            <h3 id="mediators">II. Mediators of Acute Inflammation</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p><strong>Toll-like receptors (TLRs)</strong></p>
                                        <ol>
                                            <li>Present on cells of the innate immune system (e.g., macrophages and dendritic cells)</li>
                                            <li>Activated by pathogen-associated molecular patterns (PAMPs) that are commonly shared by microbes
                                                <ol type="i">
                                                    <li>CD14 (a co-receptor for TLR4) on macrophages recognizes lipopolysaccharide (a PAMP) on the outer membrane of gram-negative bacteria.</li>
                                                </ol>
                                            </li>
                                            <li>TLR activation results in upregulation of NF-$\kappa$B, a nuclear transcription factor that activates immune response genes leading to production of multiple immune mediators.</li>
                                            <li>TLRs are also present on cells of adaptive immunity (e.g., lymphocytes) and, hence, play an important role in mediating chronic inflammation.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p><strong>Arachidonic acid (AA) metabolites</strong></p>
                                        <ol>
                                            <li>AA is released from the phospholipid cell membrane by phospholipase $A_2$ and then acted upon by cyclooxygenase or 5-lipoxygenase.
                                                <ol type="i">
                                                    <li>Cyclooxygenase produces prostaglandins (PG).
                                                        <ol type="a">
                                                            <li>$PGI_2$, $PGD_2$, and $PGE_2$ mediate vasodilation and increased vascular permeability.</li>
                                                            <li>$PGE_2$ also mediates pain and fever.</li>
                                                        </ol>
                                                    </li>
                                                    <li>5-lipoxygenase produces leukotrienes (LT).
                                                        <ol type="a">
                                                            <li>$LTB_4$ attracts and activates neutrophils.</li>
                                                            <li>$LTC_4$, $LTD_4$, and $LTE_4$ (slow reacting substances of anaphylaxis) mediate vasoconstriction, bronchospasm, and increased vascular permeability.</li>
                                                        </ol>
                                                    </li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p><strong>Mast cells</strong></p>
                                        <ol>
                                            <li>Widely distributed throughout connective tissue</li>
                                            <li>Activated by (1) tissue trauma, (2) complement proteins C3a and C5a, or (3) cross-linking of cell-surface IgE by antigen
                                                <ol type="i">
                                                    <li>Immediate response involves release of preformed histamine granules, which mediate vasodilation of arterioles and increased vascular permeability.</li>
                                                    <li>Delayed response involves production of arachidonic acid metabolites, particularly leukotrienes.</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p><strong>Complement</strong></p>
                                        <ol>
                                            <li>Proinflammatory serum proteins that "complement" inflammation</li>
                                            <li>Circulate as inactive precursors; activation occurs via
                                                <ol type="i">
                                                    <li>Classical pathway‚ÄîC1 binds IgG or IgM that is bound to antigen.</li>
                                                    <li>Alternative pathway‚ÄîMicrobial products directly activate complement.</li>
                                                    <li>Mannose-binding lectin (MBL) pathway‚ÄîMBL binds to mannose on microorganisms and activates complement.</li>
                                                </ol>
                                            </li>
                                            <li>All pathways result in production of C3 convertase (mediates $C3 \rightarrow C3a$ and C3b), which, in turn, produces C5 convertase (mediates $C5 \rightarrow C5a$ and C5b). C5b complexes with C6-C9 to form the membrane attack complex (MAC).
                                                <ol type="i">
                                                    <li>C3a and C5a (anaphylatoxins)‚Äîtrigger mast cell degranulation, resulting in histamine-mediated vasodilation and increased vascular permeability</li>
                                                    <li>C5a‚Äîchemotactic for neutrophils</li>
                                                    <li>C3b‚Äîopsonin for phagocytosis</li>
                                                    <li>MAC‚Äîlyses microbes by creating a hole in the cell membrane</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">E</span>
                                    <div class="list-content">
                                        <p><strong>Hageman factor (Factor XII)</strong></p>
                                        <ol>
                                            <li>Inactive proinflammatory protein produced in liver</li>
                                            <li>Activated upon exposure to subendothelial or tissue collagen; in turn, activates
                                                <ol type="i">
                                                    <li>Coagulation and fibrinolytic systems</li>
                                                    <li>Complement</li>
                                                    <li>Kinin system‚ÄîKinin cleaves high-molecular-weight kininogen (HMWK) to bradykinin, which mediates vasodilation and increased vascular permeability (similar to histamine), as well as pain.</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="cardinal-signs">III. Cardinal Signs of Inflammation</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <strong>Redness (rubor) and warmth (calor)</strong>
                                        <ol>
                                            <li>Due to vasodilation, which results in increased blood flow</li>
                                            <li>Occurs via relaxation of arteriolar smooth muscle; key mediators are histamine, prostaglandins, and bradykinin.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <strong>Swelling (tumor)</strong>
                                        <ol>
                                            <li>Due to leakage of fluid from postcapillary venules into the interstitial space (exudate)</li>
                                            <li>Key mediators are (1) histamine, which causes endothelial cell contraction and (2) tissue damage, resulting in endothelial cell disruption.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <strong>Pain (dolor)</strong>
                                        <ol>
                                            <li>Bradykinin and $PGE_2$ sensitize sensory nerve endings.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <strong>Fever</strong>
                                        <ol>
                                            <li>Pyrogens (e.g., LPS from bacteria) cause macrophages to release IL-1 and TNF, which increase cyclooxygenase activity in perivascular cells of the hypothalamus.</li>
                                            <li>Increased $PGE_2$ raises temperature set point.</li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="neutrophil-function">IV. Neutrophil Arrival and Function</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <strong>Step 1‚ÄîMargination</strong>
                                        <ol>
                                            <li>Vasodilation slows blood flow in postcapillary venules.</li>
                                            <li>Cells marginate from center of flow to the periphery.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <strong>Step 2‚ÄîRolling</strong>
                                        <ol>
                                            <li>Selectin "speed bumps" are upregulated on endothelial cells.
                                                <ol type="i">
                                                    <li>P-selectin release from Weibel-Palade bodies is mediated by histamine.</li>
                                                    <li>E-selectin is induced by TNF and IL-1.</li>
                                                </ol>
                                            </li>
                                            <li>Selectins bind sialyl Lewis X on leukocytes.</li>
                                            <li>Interaction results in rolling of leukocytes along vessel wall.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <strong>Step 3‚ÄîAdhesion</strong>
                                        <ol>
                                            <li>Cellular adhesion molecules (ICAM and VCAM) are upregulated on endothelium by TNF and IL-1.</li>
                                            <li>Integrins are upregulated on leukocytes by C5a and $LTB_4$.</li>
                                            <li>Interaction between CAMs and integrins results in firm adhesion of leukocytes to the vessel wall.</li>
                                            <li>Leukocyte adhesion deficiency is most commonly due to an autosomal recessive defect of integrins (CD18 subunit).
                                                <ol type="i">
                                                    <li>Clinical features include delayed separation of the umbilical cord, increased circulating neutrophils (due to impaired adhesion of marginated pool of leukocytes), and recurrent bacterial infections that lack pus formation.</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <strong>Step 4‚ÄîTransmigration and Chemotaxis</strong>
                                        <ol>
                                            <li>Leukocytes transmigrate across the endothelium of postcapillary venules and move toward chemical attractants (chemotaxis).</li>
                                            <li>Neutrophils are attracted by bacterial products, IL-8, C5a, and $LTB_4$.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">E</span>
                                    <div class="list-content">
                                        <strong>Step 5‚ÄîPhagocytosis</strong>
                                        <ol>
                                            <li>Consumption of pathogens or necrotic tissue; phagocytosis is enhanced by opsonins (IgG and C3b).</li>
                                            <li>Pseudopods extend from leukocytes to form phagosomes, which are internalized and merge with lysosomes to produce phagolysosomes.</li>
                                            <li>Chediak-Higashi syndrome is a protein trafficking defect (autosomal recessive) characterized by impaired phagolysosome formation. Clinical features include
                                                <ol type="i">
                                                    <li>Increased risk of pyogenic infections</li>
                                                    <li>Neutropenia (due to intramedullary death of neutrophils)</li>
                                                    <li>Giant granules in leukocytes (due to fusion of granules arising from the Golgi apparatus)</li>
                                                    <li>Defective primary hemostasis (due to abnormal dense granules in platelets)</li>
                                                    <li>Albinism</li>
                                                    <li>Peripheral neuropathy</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">F</span>
                                    <div class="list-content">
                                        <strong>Step 6‚ÄîDestruction of phagocytosed material</strong>
                                        <ol>
                                            <li>$O_2$-dependent killing is the most effective mechanism.</li>
                                            <li>HOCl generated by oxidative burst in phagolysosomes destroys phagocytosed microbes.
                                                <ol type="i">
                                                    <li>$O_2$ is converted to $O_2^{\bullet-}$ by NADPH oxidase (oxidative burst).</li>
                                                    <li>$O_2^{\bullet-}$ is converted to $H_2O_2$ by superoxide dismutase (SOD).</li>
                                                    <li>$H_2O_2$ is converted to HOCl (bleach) by myeloperoxidase (MPO).</li>
                                                </ol>
                                            </li>
                                            <li>Chronic granulomatous disease (CGD) is characterized by poor $O_2$-dependent killing.
                                                <ol type="i">
                                                    <li>Due to NADPH oxidase defect (X-linked or autosomal recessive)</li>
                                                    <li>Leads to recurrent infection and granuloma formation with catalase-positive organisms, particularly Staphylococcus aureus, Pseudomonas cepacia, Serratia marcescens, Nocardia, and Aspergillus</li>
                                                    <li>Nitroblue tetrazolium test is used to screen for CGD. Leukocytes are incubated with NBT dye, which turns blue if NADPH oxidase can convert $O_2$ to $O_2^{\bullet-}$, but remains colorless if NADPH oxidase is defective.</li>
                                                </ol>
                                            </li>
                                            <li>MPO deficiency results in defective conversion of $H_2O_2$ to HOCl.
                                                <ol type="i">
                                                    <li>Increased risk for Candida infections; however, most patients are asymptomatic.</li>
                                                    <li>NBT is normal; respiratory burst ($O_2$ to $H_2O_2$) is intact.</li>
                                                </ol>
                                            </li>
                                            <li>$O_2$-independent killing is less effective than $O_2$-dependent killing and occurs via enzymes present in leukocyte secondary granules (e.g., lysozyme in macrophages and major basic protein in eosinophils).</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">G</span>
                                    <div class="list-content">
                                        <strong>Step 7‚ÄîResolution</strong>
                                        <ol>
                                            <li>Neutrophils undergo apoptosis and disappear within 24 hours after resolution of the inflammatory stimulus.</li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="macrophages">V. Macrophages</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p>Macrophages predominate after neutrophils and peak 2-3 days after inflammation begins.</p>
                                        <ol>
                                            <li>Derived from monocytes in blood</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Arrive in tissue via the margination, rolling, adhesion, and transmigration sequence</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">Ingest organisms via phagocytosis (augmented by opsonins) and destroy phagocytosed material using enzymes (e.g., lysozyme) in secondary granules ($O_2$ independent killing)</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>Manage the next step of the inflammatory process. Outcomes include</p>
                                        <ol>
                                            <li>Resolution and healing‚ÄîAnti-inflammatory cytokines (e.g., IL-10 and TGF-$\beta$) are produced by macrophages.</li>
                                            <li>Continued acute inflammation‚Äîmarked by persistent pus formation; IL-8 from macrophages recruits additional neutrophils.</li>
                                            <li>Abscess‚Äîacute inflammation surrounded by fibrosis; macrophages mediate fibrosis via fibrogenic growth factors and cytokines.</li>
                                            <li>Chronic inflammation‚ÄîMacrophages present antigen to activate $CD4^+$ helper T cells, which secrete cytokines that promote chronic inflammation.</li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Chronic Inflammation -->
                    <section id="chronic-inflammation" class="content-section">
                        <h2 class="section-title">Chronic Inflammation</h2>
                        
                        <div class="content-card">
                            <h3 id="chronic-basic-principles">I. Basic Principles</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Characterized by the presence of lymphocytes and plasma cells in tissue (Fig. 2.1B)</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Delayed response, but more specific (adaptive immunity) than acute inflammation</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">Stimuli include (1) persistent infection (most common cause); (2) infection with viruses, mycobacteria, parasites, and fungi; (3) autoimmune disease; (4) foreign material; and (5) some cancers.</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="t-lymphocytes">II. T Lymphocytes</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Produced in bone marrow as progenitor T cells</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>Further develop in the thymus where the T-cell receptor (TCR) undergoes rearrangement and progenitor cells become $CD4^+$ helper T cells or $CD8^+$ cytotoxic T cells</p>
                                        <ol>
                                            <li>T cells use TCR complex (TCR and CD3) for antigen surveillance.</li>
                                            <li>TCR complex recognizes antigen presented on MHC molecules.
                                                <ol type="i">
                                                    <li>$CD4^+$ T cells‚ÄîMHC class II</li>
                                                    <li>$CD8^+$ T cells‚ÄîMHC class I</li>
                                                </ol>
                                            </li>
                                            <li>Activation of T cells requires (1) binding of antigen/MHC complex and (2) an additional 2nd signal.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>$CD4^+$ helper T-cell activation</p>
                                        <ol>
                                            <li>Extracellular antigen (e.g., foreign protein) is phagocytosed, processed, and presented on MHC class II, which is expressed by antigen presenting cells (APCs).</li>
                                            <li>B7 on APC binds CD28 on $CD4^+$ helper T cells providing 2nd activation signal.</li>
                                            <li>Activated $CD4^+$ helper T cells secrete cytokines that "help" inflammation and are divided into two subsets.
                                                <ol type="i">
                                                    <li>$T_H1$ subset secretes IFN-$\gamma$ (activates macrophage, promotes B-cell class switching from IgM to IgG, promotes $T_H1$ phenotype and inhibits $T_H2$ phenotype).</li>
                                                    <li>$T_H2$ subset secretes IL-4 (facilitates B-cell class switching to IgE), IL-5 (eosinophil chemotaxis and activation, and class switching to IgA), and IL-13 (function similar to IL-4).</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>$CD8^+$ cytotoxic T-cell activation</p>
                                        <ol>
                                            <li>Intracellular antigen (derived from proteins in the cytoplasm) is processed and presented on MHC class I, which is expressed by all nucleated cells and platelets.</li>
                                            <li>IL-2 from $CD4^+ T_H1$ cell provides 2nd activation signal.</li>
                                            <li>Cytotoxic T cells are activated for killing.</li>
                                            <li>Killing occurs via
                                                <ol type="i">
                                                    <li>Secretion of perforin and granzyme; perforin creates pores that allow granzyme to enter the target cell, activating apoptosis.</li>
                                                    <li>Expression of FasL, which binds Fas on target cells, activating apoptosis</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="b-lymphocytes">III. B Lymphocytes</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Immature B cells are produced in the bone marrow and undergo immunoglobulin rearrangements to become na√Øve B cells that express surface IgM and IgD.</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>B-cell activation occurs via</p>
                                        <ol>
                                            <li>Antigen binding by surface IgM or IgD; results in maturation to IgM- or IgDsecreting plasma cells</li>
                                            <li>B-cell antigen presentation to $CD4^+$ helper T cells via MHC class II.
                                                <ol type="i">
                                                    <li>CD40 receptor on B cell binds CD40L on helper T cell, providing 2nd activation signal.</li>
                                                    <li>Helper T cell then secretes IL-4 and IL-5 (mediate B-cell isotype switching, hypermutation, and maturation to plasma cells).</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="granulomatous-inflammation">IV. Granulomatous Inflammation</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Subtype of chronic inflammation</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Characterized by granuloma, which is a collection of epithelioid histiocytes (macrophages with abundant pink cytoplasm), usually surrounded by giant cells and a rim of lymphocytes</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>Divided into noncaseating and caseating subtypes</p>
                                        <ol>
                                            <li>Noncaseating granulomas lack central necrosis (Fig. 2.2A). Common etiologies include reaction to foreign material, sarcoidosis, beryllium exposure, Crohn disease, and cat scratch disease.</li>
                                            <li>Caseating granulomas exhibit central necrosis and are characteristic of tuberculosis and fungal infections (Fig. 2.2B).</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>Steps involved in granuloma formation</p>
                                        <ol>
                                            <li>Macrophages process and present antigen via MHC class II to $CD4^+$ helper T cells.</li>
                                            <li>Interaction leads macrophages to secrete IL-12, inducing $CD4^+$ helper T cells to differentiate into $T_H1$ subtype.</li>
                                            <li>$T_H1$ cells secrete IFN-$\gamma$, which converts macrophages to epithelioid histiocytes and giant cells.</li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>

                            <div class="figure-grid">
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251213-6f1eeb68.jpeg" 
                                             alt="Granuloma subtypes: noncaseating and caseating" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.2 Granuloma. A, Noncaseating. B, Caseating.</figcaption>
                                </figure>
                            </div>
                        </div>
                    </section>

                    <!-- Primary Immunodeficiency -->
                    <section id="primary-immunodeficiency" class="content-section">
                        <h2 class="section-title">Primary Immunodeficiency</h2>

                        <div class="content-card">
                            <h3 id="digeorge-syndrome">I. DiGeorge Syndrome</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p>Developmental failure of the third and fourth pharyngeal pouches</p>
                                        <ol>
                                            <li>Due to 22q11 microdeletion</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Presents with T-cell deficiency (lack of thymus); hypocalcemia (lack of parathyroids); and abnormalities of heart, great vessels, and face</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="scid">II. Severe Combined Immunodeficiency (SCID)</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Defective cell-mediated and humoral immunity</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>Etiologies include</p>
                                        <ol>
                                            <li>Cytokine receptor defects‚ÄîCytokine signaling is necessary for proliferation and maturation of B and T cells.</li>
                                            <li>Adenosine deaminase (ADA) deficiency‚ÄîADA is necessary to deaminate adenosine and deoxyadenosine for excretion as waste products; buildup of adenosine and deoxyadenosine is toxic to lymphocytes.</li>
                                            <li>MHC class II deficiency‚ÄîMHC class II is necessary for $CD4^+$ helper T cell activation and cytokine production.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">Characterized by susceptibility to fungal, viral, bacterial, and protozoal infections, including opportunistic infections and live vaccines</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">Treatment is sterile isolation ('bubble baby') and stem cell transplantation.</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="x-linked-agammaglobulinemia">III. X-Linked Agammaglobulinemia</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p>Complete lack of immunoglobulin due to disordered B-cell maturation</p>
                                        <ol>
                                            <li>Pre- and pro-B cells cannot mature.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Due to mutated Bruton tyrosine kinase; X-linked</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">Presents after 6 months of life with recurrent bacterial, enterovirus (e.g., polio and coxsackievirus), and Giardia lamblia infections; maternal antibodies present during the first 6 months of life are protective.</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">Live vaccines (e.g., polio) must be avoided.</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="cvid">IV. Common Variable Immunodeficiency (CVID)</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Low immunoglobulin due to B-cell or helper T-cell defects</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Increased risk for bacterial, enterovirus, and Giardia lamblia infections, usually in late childhood</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">Increased risk for autoimmune disease and lymphoma</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="iga-deficiency">V. IgA Deficiency</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Low serum and mucosal IgA; most common immunoglobulin deficiency</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Increased risk for mucosal infection, especially viral; however, most patients are asymptomatic.</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="hyper-igm">VI. Hyper-IgM Syndrome</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Characterized by elevated IgM</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>Due to mutated CD40L (on helper T cells) or CD40 receptor (on B cells)</p>
                                        <ol>
                                            <li>Second signal cannot be delivered to helper T cells during B-cell activation.</li>
                                            <li>Consequently, cytokines necessary for immunoglobulin class switching are not produced.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">Low IgA, IgG, and IgE result in recurrent pyogenic infections (due to poor opsonization), especially at mucosal sites.</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="wiskott-aldrich">VII. Wiskott-Aldrich Syndrome</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Characterized by thrombocytopenia, eczema, and recurrent infections (defective humoral and cellular immunity); bleeding is a major cause of death</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Due to mutation in the WASP gene; X-linked</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="complement-deficiencies">VIII. Complement Deficiencies</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">C5-C9 deficiencies‚Äîincreased risk for Neisseria infection ($N$ gonorrhoeae and $N$ meningitidis)</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">C1 inhibitor deficiency‚Äîresults in hereditary angioedema, which is characterized by edema of the skin (especially periorbital, Fig. 2.3) and mucosal surfaces</div>
                                </li>
                            </ul>
                            
                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-38ada159.jpeg" 
                                         alt="Angioedema showing periorbital edema" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.3 Angioedema. (Courtesy of James Heilman, MD, Wikipedia)</figcaption>
                            </figure>
                        </div>
                    </section>

                    <!-- Autoimmune Disorders -->
                    <section id="autoimmune-disorders" class="content-section">
                        <h2 class="section-title">Autoimmune Disorders</h2>

                        <div class="content-card">
                            <h3 id="autoimmune-principles">I. Basic Principles</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p>Characterized by immune-mediated damage of self tissues</p>
                                        <ol>
                                            <li>US prevalence is $1\%-2\%$.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>Involves loss of self-tolerance</p>
                                        <ol>
                                            <li>Self-reactive lymphocytes are regularly generated but develop central (thymus and bone marrow) or peripheral tolerance.</li>
                                            <li>Central tolerance in thymus leads to T-cell (thymocyte) apoptosis or generation of regulatory T cells.
                                                <ol type="i">
                                                    <li>AIRE mutations result in autoimmune polyendocrine syndrome.</li>
                                                </ol>
                                            </li>
                                            <li>Central tolerance in bone marrow leads to receptor editing or B-cell apoptosis.</li>
                                            <li>Peripheral tolerance leads to anergy or apoptosis of T and B cells.
                                                <ol type="i">
                                                    <li>Fas apoptosis pathway mutations result in autoimmune lymphoproliferative syndrome (ALPS).</li>
                                                </ol>
                                            </li>
                                            <li>Regulatory T cells suppress autoimmunity by blocking T-cell activation and producing anti-inflammatory cytokines (IL-10 and TGF-$\beta$).
                                                <ol type="i">
                                                    <li>CD25 polymorphisms are associated with autoimmunity (MS and type 1 DM).</li>
                                                    <li>FOXP3 mutations lead to IPEX syndrome (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked).</li>
                                                </ol>
                                            </li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>More common in women; classically affects women of childbearing age</p>
                                        <ol>
                                            <li>Estrogen may reduce apoptosis of self-reactive B cells.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>Etiology is likely an environmental trigger in genetically-susceptible individuals.</p>
                                        <ol>
                                            <li>Increased incidence in twins</li>
                                            <li>Association with certain HLA types (e.g., HLA-B27) and PTPN22 polymorphisms</li>
                                            <li>Environmental triggers lead to bystander activation or molecular mimicry.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">E</span>
                                    <div class="list-content">Autoimmune disorders are clinically progressive with relapses and remissions and often show overlapping features; partially explained by epitope spreading</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="sle">II. Systemic Lupus Erythematosus</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p>Chronic, systemic autoimmune disease</p>
                                        <ol>
                                            <li>Flares and remissions are common.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>Classically arises in middle-aged females, especially African American and Hispanic women</p>
                                        <ol>
                                            <li>May also arise in children and older adults (less dramatic gender bias)</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>Antigen-antibody complexes damage multiple tissues (type III HSR).</p>
                                        <ol>
                                            <li>Poorly-cleared apoptotic debris (e.g., from UV damage) activates self-reactive lymphocytes, which then produce antibodies to host nuclear antigens.</li>
                                            <li>Antigen-antibody complexes are generated at low levels and taken up by dendritic cells.</li>
                                            <li>DNA antigens activate TLRs, amplifying immune response (IFN-$\alpha$).</li>
                                            <li>Antigen-antibody complexes are subsequently generated at higher levels and deposit in multiple tissues causing disease.</li>
                                            <li>Deficiency of early complement proteins (C1q, C4, and C2) is associated with SLE.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>Almost any tissue can be involved. Classic findings include</p>
                                        <ol>
                                            <li>Fever, weight loss, fatigue, lymphadenopathy, and Raynaud phenomenon</li>
                                            <li>Malar 'butterfly' rash (Fig. 2.4A) or discoid rash (Fig. 2.4B), especially upon exposure to sunlight</li>
                                            <li>Oral or nasopharyngeal ulcers (usually painless)</li>
                                            <li>Arthritis (usually involving $\ge 2$ joints)</li>
                                            <li>Serositis (pleuritis and pericarditis)</li>
                                            <li>Psychosis or seizures</li>
                                            <li>Renal damage
                                                <ol type="i">
                                                    <li>Diffuse proliferative glomerulonephritis is the most common and most severe form of injury.</li>
                                                    <li>Other patterns of injury (e.g., membranous glomerulonephritis) also occur.</li>
                                                </ol>
                                            </li>
                                            <li>Anemia, thrombocytopenia, or leukopenia (type II HSR)</li>
                                            <li>Libman-Sacks endocarditis</li>
                                            <li>Antinuclear antibody (ANA; sensitive, but not specific)</li>
                                            <li>Anti-dsDNA or anti-Sm antibodies (highly specific)</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">E</span>
                                    <div class="list-content">
                                        <p>Antiphospholipid antibody is associated with SLE (one-third of patients).</p>
                                        <ol>
                                            <li>Autoantibody directed against proteins bound to phospholipids</li>
                                            <li>Important antiphospholipid antibodies include anticardiolipin (false-positive VDRL and RPR syphilis screening tests), anti-$\beta_2$-glycoprotein I, and lupus anticoagulant (falsely-elevated PTT).</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">F</span>
                                    <div class="list-content">
                                        <p>Antiphospholipid antibody syndrome is characterized by hypercoagulable state due to antiphospholipid antibodies (especially lupus anticoagulant).</p>
                                        <ol>
                                            <li>Results in arterial and venous thrombosis including deep venous, hepatic vein, placental (recurrent pregnancy loss), and cerebral (stroke) thrombosis</li>
                                            <li>Requires lifelong anticoagulation</li>
                                            <li>Associated with SLE; however, more commonly occurs as a primary disorder</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">G</span>
                                    <div class="list-content">
                                        <p>Antihistone antibody is characteristic of drug-induced lupus.</p>
                                        <ol>
                                            <li>Procainamide, hydralazine, and isoniazid are common causes.</li>
                                            <li>ANA is positive by definition.</li>
                                            <li>CNS and renal involvement are rare.</li>
                                            <li>Removal of drug usually results in remission.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">H</span>
                                    <div class="list-content">First-line treatment includes avoiding exposure to direct sunlight and glucocorticoids for flares; other immunosuppressive agents are useful in severe or refractory disease.</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">I</span>
                                    <div class="list-content">5-year survival is $>90\%$; renal failure, infection, and accelerated coronary atherosclerosis (occurs late) are common causes of death.</div>
                                </li>
                            </ul>

                            <div class="figure-grid">
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251213-43d0cc7a.jpeg" 
                                             alt="Malar butterfly rash of SLE" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.4A Malar 'butterfly' rash, SLE.</figcaption>
                                </figure>
                                
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251213-4a604665.jpeg" 
                                             alt="Discoid rash of SLE" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.4B Discoid rash, SLE.</figcaption>
                                </figure>
                            </div>
                        </div>

                        <div class="content-card">
                            <h3 id="sjogren-syndrome">III. Sj√∂gren Syndrome</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p>Autoimmune destruction of lacrimal and salivary glands</p>
                                        <ol>
                                            <li>Lymphocyte-mediated damage (type IV HSR) with fibrosis</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>Classically presents as dry eyes (keratoconjunctivitis sicca), dry mouth (xerostomia), and recurrent dental caries in an older woman (50-60 years)‚Äî"Can't chew a cracker, dirt in my eyes"</p>
                                        <ol>
                                            <li>May progress to ulceration of corneal epithelium and oral mucosa</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>Can be primary (sicca syndrome) or associated with another autoimmune disorder, especially rheumatoid arthritis</p>
                                        <ol>
                                            <li>Rheumatoid factor is often present even when rheumatoid arthritis is absent.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>Characterized by ANA and anti-ribonucleoprotein antibodies (anti-SSA/Ro and anti-SSB/La)</p>
                                        <ol>
                                            <li>Anti-SSA and anti-SSB are associated with extraglandular manifestations (e.g., neuropathy).</li>
                                            <li>Pregnant women with anti-SSA are at risk for delivering babies with neonatal lupus and congenital heart block.</li>
                                            <li>Anti-SSA and anti-SSB are also seen in a subset of patients with SLE (screen pregnant patients)</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">E</span>
                                    <div class="list-content">Lymphocytic sialadenitis on lip biopsy (minor salivary glands) is an additional diagnostic criterion (Fig. 2.4C).</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">F</span>
                                    <div class="list-content">Increased risk for B-cell (marginal zone) lymphoma, which presents as unilateral enlargement of the parotid gland late in disease course</div>
                                </li>
                            </ul>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-6999f6c4.jpeg" 
                                         alt="Lymphocytic infiltration of salivary glands" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.4C Lymphocytic sialadenitis, Sj√∂gren syndrome.</figcaption>
                            </figure>
                        </div>

                        <div class="content-card">
                            <h3 id="systemic-sclerosis">IV. Systemic Sclerosis (Scleroderma)</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p>Autoimmune disorder characterized by sclerosis of skin and visceral organs</p>
                                        <ol>
                                            <li>Classically presents in middle-aged females (30-50 years)</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>Fibroblast activation leads to deposition of collagen.</p>
                                        <ol>
                                            <li>Autoimmune damage to mesenchyme is possible initiating event.</li>
                                            <li>Endothelial dysfunction leads to inflammation (increased adhesion molecules), vasoconstriction (increased endothelin and decreased NO), and secretion of growth factors (TGF-$\beta$ and PDGF).</li>
                                            <li>Fibrosis, initially perivascular, progresses and causes organ damage.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>Limited type‚ÄîSkin involvement is limited (hands and face) with late visceral involvement.</p>
                                        <ol>
                                            <li>Prototype is CREST syndrome: Calcinosis/anti-Centromere antibodies, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly (Fig. 2.4D), and Telangiectasias of the skin.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>Diffuse type‚ÄîSkin involvement is diffuse with early visceral involvement.</p>
                                        <ol>
                                            <li>Any organ can be involved.</li>
                                            <li>Commonly involved organs include
                                                <ol type="i">
                                                    <li>Vessels (Raynaud phenomenon)</li>
                                                    <li>GI tract (esophageal dysmotility and reflux)</li>
                                                    <li>Lungs (interstitial fibrosis and pulmonary hypertension)</li>
                                                    <li>Kidneys (scleroderma renal crisis)</li>
                                                </ol>
                                            </li>
                                            <li>Highly associated with antibodies to DNA topoisomerase I (anti-Scl-70).</li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251213-5cbe60bc.jpeg" 
                                         alt="Sclerodactyly of the hands" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 2.4D Sclerodactyly, scleroderma.</figcaption>
                            </figure>
                        </div>

                        <div class="content-card">
                            <h3 id="mixed-connective-tissue">V. Mixed Connective Tissue Disease</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Autoimmune-mediated tissue damage with mixed features of SLE, systemic sclerosis, and polymyositis</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Characterized by ANA along with serum antibodies to U1 ribonucleoprotein</div>
                                </li>
                            </ul>
                        </div>
                    </section>

                    <!-- Wound Healing -->
                    <section id="wound-healing" class="content-section">
                        <h2 class="section-title">Wound Healing</h2>

                        <div class="content-card">
                            <h3 id="healing-principles">I. Basic Principles</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Healing is initiated when inflammation begins.</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Occurs via a combination of regeneration and repair</div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="regeneration">II. Regeneration</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Replacement of damaged tissue with native tissue; dependent on regenerative capacity of tissue</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Tissues are divided into three types based on regenerative capacity: labile, stable, and permanent.</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>Labile tissues possess stem cells that continuously cycle to regenerate the tissue.</p>
                                        <ol>
                                            <li>Small and large bowel (stem cells in mucosal crypts, Fig. 2.5)</li>
                                            <li>Skin (stem cells in basal layer, Fig. 2.6)</li>
                                            <li>Bone marrow (hematopoietic stem cells)</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>Stable tissues are comprised of cells that are quiescent ($G_0$), but can reenter the cell cycle to regenerate tissue when necessary.</p>
                                        <ol>
                                            <li>Classic example is regeneration of liver by compensatory hyperplasia after partial resection. Each hepatocyte produces additional cells and then reenters quiescence.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">E</span>
                                    <div class="list-content">Permanent tissues lack significant regenerative potential (e.g., myocardium, skeletal muscle, and neurons).</div>
                                </li>
                            </ul>

                            <div class="figure-grid">
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251213-8af2bc0c.jpeg" 
                                             alt="Intestinal crypts" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.5 Intestinal crypts.</figcaption>
                                </figure>
                                
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251213-63a3cd65.jpeg" 
                                             alt="Basal layer of skin" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.6 Basal layer of skin.</figcaption>
                                </figure>
                            </div>
                        </div>

                        <div class="content-card">
                            <h3 id="repair">III. Repair</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Replacement of damaged tissue with fibrous scar</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Occurs when regenerative stem cells are lost (e.g., deep skin cut) or when a tissue lacks regenerative capacity (e.g., healing after a myocardial infarction, Fig. 2.7)</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>Granulation tissue formation is the initial phase of repair (Fig. 2.8).</p>
                                        <ol>
                                            <li>Consists of fibroblasts (deposit type III collagen), capillaries (provide nutrients), and myofibroblasts (contract wound)</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">
                                        <p>Eventually results in scar formation, in which type III collagen is replaced with type I collagen</p>
                                        <ol>
                                            <li>Type III collagen is pliable and present in granulation tissue, embryonic tissue, uterus, and keloids.</li>
                                            <li>Type I collagen has high tensile strength and is present in skin, bone, tendons, and most organs.</li>
                                            <li>Collagenase removes type III collagen and requires zinc as a cofactor.</li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>

                            <div class="figure-grid">
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251213-5b28de03.jpeg" 
                                             alt="Myocardial scarring" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.7 Myocardial scarring. (Courtesy of Aliya Husain, MD)</figcaption>
                                </figure>
                                
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251213-6c734d88.jpeg" 
                                             alt="Granulation tissue" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.8 Granulation tissue.</figcaption>
                                </figure>
                            </div>
                        </div>

                        <div class="content-card">
                            <h3 id="regeneration-repair-mechanisms">IV. Mechanisms of Tissue Regeneration and Repair</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">Mediated by paracrine signaling via growth factors (e.g., macrophages secrete growth factors that target fibroblasts)</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">Interaction of growth factors with receptors (e.g., epidermal growth factor with growth factor receptor) results in gene expression and cellular growth.</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">
                                        <p>Examples of mediators include</p>
                                        <ol>
                                            <li>TGF-$\alpha$‚Äîepithelial and fibroblast growth factor</li>
                                            <li>TGF-$\beta$‚Äîimportant fibroblast growth factor; also inhibits inflammation</li>
                                            <li>Platelet-derived growth factor‚Äîgrowth factor for endothelium, smooth muscle, and fibroblasts</li>
                                            <li>Fibroblast growth factor‚Äîimportant for angiogenesis; also mediates skeletal development</li>
                                            <li>Vascular endothelial growth factor (VEGF)‚Äîimportant for angiogenesis</li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>
                        </div>

                        <div class="content-card">
                            <h3 id="aberrant-wound-healing">V. Normal and Aberrant Wound Healing</h3>
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker">A</span>
                                    <div class="list-content">
                                        <p>Cutaneous healing occurs via primary or secondary intention.</p>
                                        <ol>
                                            <li>Primary intention‚ÄîWound edges are brought together (e.g., suturing of a surgical incision); leads to minimal scar formation</li>
                                            <li>Secondary intention‚ÄîEdges are not approximated. Granulation tissue fills the defect; myofibroblasts then contract the wound, forming a scar.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">B</span>
                                    <div class="list-content">
                                        <p>Delayed wound healing occurs in</p>
                                        <ol>
                                            <li>Infection (most common cause; $S$ aureus is the most common offender)</li>
                                            <li>Vitamin C, copper, or zinc deficiency
                                                <ol type="i">
                                                    <li>Vitamin C is an important cofactor in the hydroxylation of proline and lysine procollagen residues; hydroxylation is necessary for eventual collagen cross-linking.</li>
                                                    <li>Copper is a cofactor for lysyl oxidase, which cross-links lysine and hydroxylysine to form stable collagen.</li>
                                                    <li>Zinc is a cofactor for collagenase, which replaces the type III collagen of granulation tissue with stronger type I collagen.</li>
                                                </ol>
                                            </li>
                                            <li>Other causes include foreign body, ischemia, diabetes, and malnutrition.</li>
                                        </ol>
                                    </div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">C</span>
                                    <div class="list-content">Dehiscence is rupture of a wound; most commonly seen after abdominal surgery</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">D</span>
                                    <div class="list-content">Hypertrophic scar is excess production of scar tissue that is localized to the wound (Fig. 2.9).</div>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker">E</span>
                                    <div class="list-content">
                                        <p>Keloid is excess production of scar tissue that is out of proportion to the wound (Fig. 2.10).</p>
                                        <ol>
                                            <li>Characterized by excess type III collagen</li>
                                            <li>Genetic predisposition (more common in African Americans)</li>
                                            <li>Classically affects earlobes, face, and upper extremities</li>
                                        </ol>
                                    </div>
                                </li>
                            </ul>

                            <div class="figure-grid">
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <img src="../assets/images/image-20251213-9b090b79.jpeg" 
                                             alt="Hypertrophic scar" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.9 Hypertrophic scar. (Reprinted with permission, http://emedicine.medscape.com/ article/1128404-overview)</figcaption>
                                </figure>
                                
                                <figure class="content-figure" data-lightbox="true">
                                    <div class="figure-image-wrapper">
                                        <!-- Note: Prompt implied 2.9 and 2.10 might share an image or be close. Using the same reference if distinct one not provided, but usually they are distinct. I will leave this placeholder if specific image for Keloid is not found in the list, but source text implies there is one. -->
                                        <img src="../assets/images/image-20251213-9b090b79.jpeg" 
                                             alt="Keloid scar" 
                                             class="figure-image"
                                             loading="lazy">
                                        <div class="figure-overlay">
                                            <span class="overlay-icon">üîç</span>
                                            <span class="overlay-text">Click to enlarge</span>
                                        </div>
                                    </div>
                                    <figcaption class="figure-caption">Fig. 2.10 Keloid.</figcaption>
                                </figure>
                            </div>
                        </div>
                    </section>
                    <!-- END: Wound Healing -->

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="chapter-01-growth-adaptations.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Growth Adaptations, Cellular Injury, and Cell Death</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="chapter-03-neoplasia.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">Principles of Neoplasia</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- JavaScript Dependencies -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>